Innovation1 Biotech Inc.
IVBT
$0.0002
-$0.0048-96.00%
OTC PK
| 02/29/2024 | 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 104.76% | -48.67% | -68.18% | -87.94% | -95.99% |
| Total Receivables | -- | -- | -85.99% | 0.00% | -68.63% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -65.86% | -78.72% | -79.73% | -76.68% | 9.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -16.34% | -85.83% | -74.67% | -80.14% | -90.66% |
|
|
|||||
| Total Current Assets | -16.34% | -85.83% | -74.67% | -80.14% | -90.66% |
| Net Property, Plant & Equipment | -52.38% | -99.70% | -99.67% | -99.66% | -99.64% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -99.95% | -99.95% | -100.00% | -95.76% | -95.80% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 416.67% | 416.67% |
| Total Assets | -96.83% | -99.53% | -99.83% | -95.25% | -95.37% |
|
|
|||||
| Total Accounts Payable | 11.58% | 74.98% | 228.91% | 128.97% | 212.80% |
| Total Accrued Expenses | -58.99% | -41.49% | 653.35% | 1,716.29% | 5,481.60% |
| Short-term Debt | 400.00% | 400.00% | 0.00% | 0.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 69.00% | 91.14% | -94.04% | -94.75% | -95.48% |
| Total Other Current Liabilities | 69.00% | 91.14% | -94.04% | -94.75% | -95.48% |
| Total Current Liabilities | 24.36% | 38.76% | -88.97% | -91.55% | -92.02% |
|
|
|||||
| Total Current Liabilities | 24.36% | 38.76% | -88.97% | -91.55% | -92.02% |
| Long-Term Debt | 2,378.13% | 15,255.56% | -- | -- | -- |
| Short-term Debt | 400.00% | 400.00% | 0.00% | 0.00% | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 46.73% | 42.02% | -91.47% | -93.63% | -94.20% |
|
|
|||||
| Common Stock & APIC | 2.42% | 18.01% | 16.45% | 16.45% | 15.83% |
| Retained Earnings | -11.50% | -30.15% | -31.60% | -658.30% | -904.85% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -327.52% | -247.37% | -220.86% | -96.91% | -96.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | -327.52% | -247.37% | -220.86% | -96.91% | -96.51% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -325.73% | -246.42% | -220.24% | -96.89% | -96.49% |
|
|
|||||